Boston Marathon Winner Finishes in Compression Socks

The first American man to win the Boston Marathon since 1983 crossed the finish line last week.  Meb Keflezighi, 38 , won the men’s division while wearing CEP compression, a line of Mediven medical compression stockings. Meb has been publicly wearing CEP compression socks for years, including as the US Olympic marathon runner.

images

CEP Compression

Due to the health benefits that come from compression socks, other athletes are also using compression socks to decrease muscle fatigue and improve performance and recovery. It seems as though every runner is wearing compression socks these days.  Compression is not just for athletes. Compression has been used for decades as the treatment for vein disorders. In the field of venous disease, they are the gold standard in conservative management for vein conditions such as varicose veins and venous insufficiency. For those who have jobs that require prolonged periods of standing or sitting, compression can help with occupational leg swelling and fatigue. They are also recommended during air travel to reduce the risk of deep venous thrombosis (DVT).

CEP Compression socks, like those worn by Meb Keflezighi in the Boston Marathon can be found at CompressRx.com.

La Jolla Vein Care Chosen To Participate in Compression Trial

La Jolla Vein Care Participates in ACTitouch Adaptive Compression Therapy Trial
compression pump

La Jolla Vein Care participates in compression therapy trial

Selected patients at La Jolla Vein Care will be offered to participate in the ACTitouch compression trial.  Compression therapy is used for the treatment and prevention of vein disorders in the form of compression garments like compression socks and stockings, multi-layer wrappings, gel paste boots or devices such lymphatic pumps. The ACTitouch is a new compression device designed for ease of use and comfort.  The ACTitouch Adaptive Compression Therapy system combines two proven therapies—intermittent pneumatic compression and sustained gradient compression—in one easy-to-wear device. It is designed to mimic the action of the calf muscle pump through application of optimal gradient pressures.  It is lightweight and compact, so it may give you the freedom to stay active while helping you reduce edema and heal venous leg ulcers. Because it is easy to use, the ACTitouch system may help promote greater patient compliance.  The study will assess whether or not patients who are unable to wear compression garments are more compliant with using the ACTitouch system because it is easier to use.   This device may offer effective daily at-home treatment of venous insufficiency for those who cannot use other types of compression.

 

 

 

New Foam Treatment of Varicose Veins

In November of 2013, the US Food and Drug Administration (FDA)  approved Varithena,™   a new type of foam treatment for the treatment of patients with incompetent veins and visible varicosities of the great saphenous vein (GSV) system. Varithena is a pharmaceutical-grade, low-nitrogen, polidocanol foam dispensed from a canister device. In two pivotal, placebo-controlled Phase III trials, VANISH-1 and VANISH-2, Varithena achieved a clinically meaningful improvement in the symptoms of superficial venous incompetence and the appearance of visible varicosities and addressed the underlying venous incompetence in the majority of patients treated. Varithena (polidocanol injectable foam) is a sclerosing agent indicated for the treatment of incompetent great saphenous veins, accessory saphenous veins and visible varicosities of the great saphenous vein system above and below the knee.  Varithena improves the symptoms of superficial venous incompetence and the appearance of visible varicosities.  Treatment is a minimally invasive, non-surgical procedure that requires neither tumescent anesthesia nor sedation.  Foam sclerotherapy has been used for years by medical doctors. What is new with Varithena , is that the foam is pre-made with low-nitrogen as opposed to room air, and is dispensed in a proprietary canister.   It is not yet available in doctors offices. Making Foam

Oxford University Press releases The Vein Book

The second edition of The Vein Book, edited by Dr. Nisha Bunke Paquette and Dr. John Bergan will be released on January 30th, 2014 by the Oxford University Press.

Since its initial publication nearly a decade ago, The Vein Book continues to serves as the ultimate comprehensive resource on venous disease. Upholding its reputation as the go-to reference for complete, authoritative, and up-to-date information about venous function and dysfunction, this second edition effectively bridges the gap between clinical medicine and basic science, suitable both for the seasoned surgeon as well as the medical student.

La Jolla Vein Care's Dr. Bunke releases The Vein Book

La Jolla Vein Care’s Dr. Bunke releases The Vein Book

The book is divided into five essential sections: basic considerations, primary superficial venous insufficiency, venous thromboembolism, chronic venous insufficiency, and congenital venous malformations. The book covers the entire spectrum of venous conditions from clarification of the pathophysiology of venous insufficiency, molecular mechanisms in the cause of varicose veins, new treatment options for varicose veins and spider veins, startling new treatment for venous thromboembolic disease, and effective treatment for leg ulcers.

More user-friendly and encyclopedic than ever, The Vein Book is still a must-have for vascular surgeons, phlebologists, interventional radiologists, research scientists, epidemiologists, and surgeons at all levels.  It is available for pre-order at Amazon.com.

New Varicose Vein Treatments 2014: Clarivein

CLARIVEIN Procedure to Treat Varicose Veins

The newest alternative to vein stripping surgery, and endovenous ablation procedures is Clarivein. The ClariVein procedure, also known as mechanochemical ablation (MOCA) utilizes a wire and sclerosant medication to seal shut incompetent veins. It can be performed in the office in less than an hour without using a local anesthetic.  A thin catheter is introduced into the vein under ultrasound guidance. A sclerosant medication, such as is used in sclerotherapy, is delivered via the catheter, to seal the veins shut. La Jolla Vein Care is one of the few southern California vein centers to offer the Clarivein, or mechanochemical ablation procedure. To read more about Clarivein, go to www.lajollaveincare.com.

Clarivein insertion

Clarivein insertion

 

Delivery of Sclerosant Solution

Delivery of Sclerosant Solution

 

La Jolla Vein Care Receives BBB Accreditation

La Jolla Vein Care is pleased to announce that it is among the handful of medical practices that is accredited by the Better Business Bureau (BBB) in San Diego.  The BBB was founded in 1912 and its accreditation means BBB has determined that the business meets accreditation standards which include a commitment to ethical practices and a pledge to continue to adhere to the BB Code of Business Practices.  The BBB Code of Business Practices is built on the BBB Standards for Trust, including eight principles that summarize important elements of creating and maintaining trust in business.

La Jolla Vein Care Distinguished Doctors Invited to World Congress

La Jolla Vein Care Doctors, Drs. Helane Fronek and Bunke-Paquette were Invited to participate in the Union International de Phlebology World Congress, which was held in Boston September 9th-12th. The World Congress is held every four years and includes key leaders and rule makers in the field of venous and lymphatic disorders from around the world. At the last World Congress held in Monaco in 2009, Dr. Bunke was awarded the UIP fellowship award. At this years conference, Dr. Helane Fronek was invited to speak about ‘Which Compression in Mixed, Arterial-Venous Disease’ to an audience of vascular specialists and ‘Communication Matters’ at the Nursing Symposium. She was also a guest chair and led discussions about superficial venous disease. As an expert on superficial venous disease, Dr. Bunke-Paquette was invited to be a judge of original research which was presented by very distinguished MDs and PhDs. Research topics ranged from ‘sclerotherapy for chronic venous insufficiency: a report from the american venous registry’ to ‘neovascularisation and dilated pre-formed veins at saphenofemoral junction-therapy with duplex guided foam sclerotherapy’ and ‘patient follow-up after varicose vein interventions in the UK- the view of surgeons, general practitioners and patients’ and ’12 months follow up of a randomized study comparing endovenous occlusion of the incompetent great saphenous vein with radial EVLA versus RFA ClosureFast.’

World Renowned Vein Specialists Meet in Sedona

Dr. Bunke-Paquette joined 40 invited vein experts from around the world at Sedona Days 2012. The meeting, held in the ‘red rock country’ of Sedona, Arizona was hosted by Dr. Nick Morrison of the Morrison Vein Institute and was made possible by Medi who sponsored the event. Sedona Days 2012 featured many of the leading phlebologists in the world. Various topics related to the diagnosis and treatment of patients with venous disease were presented and discussed in a unique and intimate setting.

Dr. Bunke-Paquette Speaks About Venous Leg Ulcers at UCSD’s 35th Annual Assembly In Surgery Conference

On Friday, April 20 Dr. Bunke-Paquette joined distinguished faculty to participate in UCSD’s 35th Annual Assembly in Surgery, held in the Hard Rock Hotel in San Diego, California. She discussed the modern management of venous leg ulcers to the attendees who were surgeons. One of Dr. Bunke-Paquette’s area of expertise is in the treatment of the venous leg ulcers. She discussed new methods of treatment for the venous leg ulcer. Dr. Bunke-Paquette explained how the goal of treatment is to eliminate the underlying venous insufficiency, which is the cause for the venous leg ulcer. She described non-surgical treatment methods such as foam sclerotherapy and endovenous radiofrequency and laser ablation therapies.
The 35th Annual Postgraduate Assembly in Surgery is a 4-day conference that was designed to bring the practicing surgeon up-to-date on the latest developments in general surgery and surgical specialties.

When Diabetic Patients Need Compression Socks

People with diabetes often have circulation problems that can cause swelling in their feet, ankles and legs.  There are many causes of leg swelling, not necessarily related to diabetes.  Leg swelling can be caused by more serious conditions- many of which can be associated with diabetes complications such as heart disease, venous insufficiency, and kidney disease.  Certain diabetes medication can also cause swelling.

Now, Sigvaris has introduced a compression sock for diabetic patients.  There is a difference between the diabetic compression sock and a mere diabetic sock without compression.  New research shows that for many diabetic patients, compression socks can help keep legs and feet healthy, as well as allow the patient to have a more active lifestyle.  Foot and skin care is important to the diabetic patient.  Keeping swelling under control is important in improving the skin condition and reducing complications related to leg swelling.